LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value
Hs 578T XMD16-144
0.37
uM
LJP5
3
M10
72
hr
765 846 3152 0.2684 0.0505
Hs 578T XMD16-144
1.11
uM
LJP5
1
M09
72
hr
765 808 3140 0.2573 0.0272
Hs 578T XMD16-144
1.11
uM
LJP5
2
M09
72
hr
765 860 3151 0.2729 0.0590
Hs 578T XMD16-144
1.11
uM
LJP5
3
M09
72
hr
765 797 3152 0.2528 0.0202
Hs 578T XMD16-144
3.33
uM
LJP5
1
M08
72
hr
765 658 3140 0.2095 -0.0713
Hs 578T XMD16-144
3.33
uM
LJP5
2
M08
72
hr
765 652 3151 0.2069 -0.0753
Hs 578T XMD16-144
3.33
uM
LJP5
3
M08
72
hr
765 718 3152 0.2278 -0.0306
Hs 578T XMD16-144
10
uM
LJP5
1
M07
72
hr
765 342 3140 0.1089 -0.3265
Hs 578T XMD16-144
10
uM
LJP5
2
M07
72
hr
765 349 3151 0.1107 -0.3191
Hs 578T XMD16-144
10
uM
LJP5
3
M07
72
hr
765 392 3152 0.1244 -0.2792
Hs 578T Erlotinib
0.04
uM
LJP5
1
M24
72
hr
765 3118 3140 0.9929 0.9930
Hs 578T Erlotinib
0.04
uM
LJP5
2
M24
72
hr
765 3182 3151 1.0096 1.0094
Hs 578T Erlotinib
0.04
uM
LJP5
3
M24
72
hr
765 3048 3152 0.9669 0.9673
Hs 578T Erlotinib
0.12
uM
LJP5
1
M23
72
hr
765 3054 3140 0.9725 0.9728
Hs 578T Erlotinib
0.12
uM
LJP5
2
M23
72
hr
765 3108 3151 0.9862 0.9864
Hs 578T Erlotinib
0.12
uM
LJP5
3
M23
72
hr
765 3168 3152 1.0049 1.0048
Hs 578T Erlotinib
0.37
uM
LJP5
1
M22
72
hr
765 3038 3140 0.9674 0.9677
Hs 578T Erlotinib
0.37
uM
LJP5
2
M22
72
hr
765 3105 3151 0.9852 0.9855
Hs 578T Erlotinib
0.37
uM
LJP5
3
M22
72
hr
765 2954 3152 0.9371 0.9374
Hs 578T Erlotinib
1.11
uM
LJP5
1
M21
72
hr
765 2962 3140 0.9432 0.9434
Hs 578T Erlotinib
1.11
uM
LJP5
2
M21
72
hr
765 2835 3151 0.8995 0.8990
Hs 578T Erlotinib
1.11
uM
LJP5
3
M21
72
hr
765 2987 3152 0.9475 0.9479
Hs 578T Erlotinib
3.33
uM
LJP5
1
M20
72
hr
765 2784 3140 0.8865 0.8852
Hs 578T Erlotinib
3.33
uM
LJP5
2
M20
72
hr
765 2809 3151 0.8913 0.8904
Hs 578T Erlotinib
3.33
uM
LJP5
3
M20
72
hr
765 2963 3152 0.9399 0.9402